Till Plönes

Evolutionary trajectories of small cell lung cancer under therapy

Julie George, Lukas Maas, Nima Abedpour et al. · Nature · 2024 · 90 citations · Full text

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

Martin Schüler, Kristof Cuppens, Till Plönes et al. · Nature Medicine · 2024 · 70 citations · Full text

Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes

Alexander Krohn, Theresa D. Ahrens, Arzu Yalcin et al. · PLoS ONE · 2014 · 67 citations · Full text

Dna Methylation Changes, Epithelial-mesenchymal Transition, Oncology +15

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas

Till Plönes, Alexander Krohn, Meike Burger et al. · PLoS ONE · 2012 · 36 citations · Full text

Ccl18 Serum Level, Inflammatory Lung Disease, Tumor Microenvironment +15

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Sabrina Borchert, Michael Wessolly, Jan Schmeller et al. · BMC Cancer · 2019 · 36 citations · Full text